Literature DB >> 18493866

Osteopontin expression correlates with angiogenesis and survival in malignant astrocytoma.

Koviljka Matusan-Ilijas1, Senija Behrem, Nives Jonjic, Kamelija Zarkovic, Ksenija Lucin.   

Abstract

Osteopontin (OPN) is a phosphorylated glycoprotein with diverse functions including angiogenesis, cancer development, invasion and metastasis. The aim of the study was to analyze the expression of OPN in human astrocytomas and to correlate it with angiogenesis and patients' outcome. Seventy-six human astrocytomas including eight pilocytic astrocytomas (grade I), 10 diffuse astrocytomas (grade II), 8 anaplastic astrocytomas (grade III) and 50 glioblastomas (grade IV) were immunohistochemically stained for OPN protein. The distribution of OPN staining (cytoplasmic and/or interstitial) was assessed and compared to microvessel number and patients' survival. In normal brain tissue some glial and neuronal cells showed weak cytoplasmic staining, while interstitium was negative. Astrocytomas were heterogeneous regarding the OPN expression. High cytoplasmic OPN expression in glioblastomas was associated with poor patients' survival (p = 0.012). Also, we found the association of interstitial OPN expression and angiogenesis (p = 0.033), i.e. the number of newly formed blood vessels was higher in tumors showing high interstitial OPN expression. Our results indicate the overexpression of OPN protein in astrocytoma cells and suggest the role of OPN in astrocytoma progression and angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18493866     DOI: 10.1007/s12253-008-9058-4

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  29 in total

1.  Osteopontin expression correlates with prognostic variables and survival in clear cell renal cell carcinoma.

Authors:  Koviljka Matusan; Gordana Dordevic; Darko Stipic; Vladimir Mozetic; Ksenija Lucin
Journal:  J Surg Oncol       Date:  2006-09-15       Impact factor: 3.454

2.  Vascular endothelial growth factor and osteopontin in stage I lung adenocarcinoma.

Authors:  N Shijubo; T Uede; S Kon; M Maeda; T Segawa; A Imada; M Hirasawa; S Abe
Journal:  Am J Respir Crit Care Med       Date:  1999-10       Impact factor: 21.405

3.  Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells.

Authors:  A B Tuck; D M Arsenault; F P O'Malley; C Hota; M C Ling; S M Wilson; A F Chambers
Journal:  Oncogene       Date:  1999-07-22       Impact factor: 9.867

4.  Immunohistochemical study of osteopontin in the spinal cords of rats with clip compression injury.

Authors:  Changjong Moon; Seungdam Heo; Meejung Ahn; Heechul Kim; Myungseung Shin; Ki Bum Sim; Hyung Min Kim; Taekyun Shin
Journal:  J Vet Med Sci       Date:  2004-10       Impact factor: 1.267

5.  Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using Suppression Subtractive Hybridization.

Authors:  C Colin; N Baeza; C Bartoli; F Fina; N Eudes; I Nanni; P-M Martin; L Ouafik; D Figarella-Branger
Journal:  Oncogene       Date:  2006-05-04       Impact factor: 9.867

6.  Osteopontin and its integrin receptor alpha(v)beta3 are upregulated during formation of the glial scar after focal stroke.

Authors:  J A Ellison; J J Velier; P Spera; Z L Jonak; X Wang; F C Barone; G Z Feuerstein
Journal:  Stroke       Date:  1998-08       Impact factor: 7.914

7.  Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin.

Authors:  D R Senger; S R Ledbetter; K P Claffey; A Papadopoulos-Sergiou; C A Peruzzi; M Detmar
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

Review 8.  Osteopontin: a protein with diverse functions.

Authors:  D T Denhardt; X Guo
Journal:  FASEB J       Date:  1993-12       Impact factor: 5.191

9.  Autocrine stimulation by osteopontin contributes to antiapoptotic signalling of melanocytes in dermal collagen.

Authors:  Eva Geissinger; Christin Weisser; Petra Fischer; Manfred Schartl; Claudia Wellbrock
Journal:  Cancer Res       Date:  2002-08-15       Impact factor: 12.701

10.  Tissue factor, osteopontin, alphavbeta3 integrin expression in microvasculature of gliomas associated with vascular endothelial growth factor expression.

Authors:  S Takano; K Tsuboi; Y Tomono; Y Mitsui; T Nose
Journal:  Br J Cancer       Date:  2000-06       Impact factor: 7.640

View more
  14 in total

1.  Osteopontin is up-regulated and associated with neutrophil and macrophage infiltration in glioblastoma.

Authors:  Nadia A Atai; Manju Bansal; Cheungh Lo; Joost Bosman; Wikky Tigchelaar; Klazien S Bosch; Ard Jonker; Philip C De Witt Hamer; Dirk Troost; Christopher A McCulloch; Vincent Everts; Cornelis J F Van Noorden; Jaro Sodek
Journal:  Immunology       Date:  2010-08-17       Impact factor: 7.397

2.  Anti-inflammatory effects of thymoquinone in activated BV-2 microglial cells.

Authors:  Equar Taka; Elizabeth A Mazzio; Carl B Goodman; Natalie Redmon; Hernan Flores-Rozas; Renee Reams; Selina Darling-Reed; Karam F A Soliman
Journal:  J Neuroimmunol       Date:  2015-06-27       Impact factor: 3.478

3.  Association of osteopontin expression with the prognosis of glioma patient: a meta-analysis.

Authors:  Mingfei Zhao; Hangdi Xu; Feng Liang; Jiliang He; Jianmin Zhang
Journal:  Tumour Biol       Date:  2014-09-30

4.  Elevated levels of full-length and thrombin-cleaved osteopontin during acute dengue virus infection are associated with coagulation abnormalities.

Authors:  Haorile Chagan-Yasutan; Talitha Lea Lacuesta; Lishomwa C Ndhlovu; Shigeru Oguma; Prisca Susan A Leano; Elizabeth Freda O Telan; Toru Kubo; Kouichi Morita; Toshimitsu Uede; Efren M Dimaano; Toshio Hattori
Journal:  Thromb Res       Date:  2014-05-14       Impact factor: 3.944

5.  Expression pattern of osteopontin splice variants and its functions on cell apoptosis and invasion in glioma cells.

Authors:  Wei Yan; Chunfa Qian; Peng Zhao; Junxia Zhang; Lei Shi; Jin Qian; Ning Liu; Zhen Fu; Chunshen Kang; Peiyu Pu; Yongping You
Journal:  Neuro Oncol       Date:  2010-02-08       Impact factor: 12.300

6.  Involvement of osteopontin as a core protein in craniopharyngioma calcification formation.

Authors:  SongTao Qi; GuangLong Huang; Jun Pan; Jia Li; Xi'An Zhang; LuXiong Fang; BaoGuo Liu; Wei Meng; YongMing Zhang; XiaoJun Liu
Journal:  J Neurooncol       Date:  2009-11-10       Impact factor: 4.130

7.  Evaluation of osteopontin as a potential biomarker for central nervous system embryonal tumors.

Authors:  Yi-Peng Han; Chen-Kai Ma; Shen-Qi Wang; Atsushi Enomoto; Yang Zhao; Masahide Takahashi; Jie Ma
Journal:  J Neurooncol       Date:  2014-05-31       Impact factor: 4.130

8.  Hypoxia-related molecules HIF-1α, CA9, and osteopontin : predictors of survival in patients with high-grade glioma.

Authors:  O P Erpolat; P U Gocun; M Akmansu; G Ozgun; G Akyol
Journal:  Strahlenther Onkol       Date:  2012-12-22       Impact factor: 3.621

9.  Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target.

Authors:  Jun Wei; Anantha Marisetty; Brett Schrand; Konrad Gabrusiewicz; Yuuri Hashimoto; Martina Ott; Zacharia Grami; Ling-Yuan Kong; Xiaoyang Ling; Hillary Caruso; Shouhao Zhou; Y Alan Wang; Gregory N Fuller; Jason Huse; Eli Gilboa; Nannan Kang; Xingxu Huang; Roel Verhaak; Shulin Li; Amy B Heimberger
Journal:  J Clin Invest       Date:  2018-11-19       Impact factor: 14.808

Review 10.  Clinical Application of Mesenchymal Stem Cells and Novel Supportive Therapies for Oral Bone Regeneration.

Authors:  Miguel Padial-Molina; Francisco O'Valle; Alejandro Lanis; Francisco Mesa; David M Dohan Ehrenfest; Hom-Lay Wang; Pablo Galindo-Moreno
Journal:  Biomed Res Int       Date:  2015-05-12       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.